Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumonia

被引:29
|
作者
Phung Anh Nguyen [1 ]
Islam, Mohaimenul [1 ,2 ]
Galvin, Cooper J. [1 ]
Chang, Chih-Cheng [3 ,4 ]
An, Soo Yeon [5 ]
Yang, Hsuan-Chia [4 ]
Huang, Chih-Wei [1 ]
Li, Yu-Chuan [1 ,4 ,6 ]
Iqbal, Usman [1 ,7 ]
机构
[1] Taipei Med Univ, Coll Med Sci & Technol, Int Ctr Hlth Informat Technol, Taipei 11031, Taiwan
[2] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei 11031, Taiwan
[3] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Pulm Med, New Taipei 235, Taiwan
[4] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei 11031, Taiwan
[5] Chungnam Natl Univ Hosp, Dept Cardiol, Daejeon 35015, South Korea
[6] Wan Fang Hosp, Dept Dermatol, Taipei 116, Taiwan
[7] Taipei Med Univ, Coll Publ Hlth, Global Hlth & Dev Dept, Global Hlth & Hlth Secur, Taipei 11031, Taiwan
关键词
clinical study; epidemiology; gastrointestinal diseases; pneumonia; proton pump inhibitors; OBSTRUCTIVE PULMONARY-DISEASE; STRESS-ULCER; ADULTS; HOSPITALIZATION; PREVENTION; MANAGEMENT; DIAGNOSIS; THERAPY;
D O I
10.1093/intqhc/mzaa041
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose: Proton pump inhibitors (PPIs), one of the most widely used medications, are commonly used to suppress several acid-related upper gastrointestinal disorders. Acid-suppressing medication use could be associated with increased risk of community-acquired pneumonia (CAP), although the results of clinical studies have been conflicting. Data sources: A comprehensive search of MEDLINE, EMBASE and Cochrane library and Database of Systematic Reviews from the earliest available online year of indexing up to October 2018. Study selection: We performed a systematic review and meta-analysis of observational studies to evaluate the risk of PPI use on CAP outcomes. Data extraction: Included study location, design, population, the prevalence of CAP, comparison group and other confounders. We calculated pooled odds ratio (OR) using a random-effects meta-analysis. Results of data synthesis: Of the 2577 studies screening, 11 papers were included in the systematic review and 7 studies with 65 590 CAP cases were included in the random-effects meta-analysis. In current PPI users, pooled OR for CAP was 1.86 (95% confidence interval (CI), 1.30-2.66), and in the case of recent users, OR for CAP was 1.66 (95% CI, 1.22-2.25). In the subgroup analysis of CAP, significance association is also observed in both high-dose and low-dose PPI therapy. When stratified by duration of exposure, 3-6 months PPIs users group was associated with increased risk of developing CAP (OR, 2.05; 95% CI, 1.22-3.45). There was a statistically significant association between the PPI users and the rate of hospitalization (OR, 2.59; 95% CI, 1.83-3.66). Conclusion: We found possible evidence linking PPI use to an increased risk of CAP. More randomized controlled studies are warranted to clarify an understanding of the association between PPI use and risk of CAP because observational studies cannot clarify whether the observed epidemiologic association is a causal effect or a result of unmeasured/residual confounding.
引用
收藏
页码:292 / 299
页数:8
相关论文
共 50 条
  • [41] Macrolides vs. quinolones for community-acquired pneumonia: meta-analysis of randomized controlled trials
    Skalsky, K.
    Yahav, D.
    Lador, A.
    Eliakim-Raz, N.
    Leibovici, L.
    Paul, M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 (04) : 370 - 378
  • [42] Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies
    Poly, T. N.
    Islam, M. M.
    Yang, H. -C.
    Wu, C. C.
    Li, Y. -C.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 (01) : 103 - 114
  • [43] Systematic review and meta-analysis of comorbidities and associated risk factors in Indian patients of community-acquired pneumonia
    Ghia, Canna Jagdish
    Rambhad, Gautam Sudhakar
    SAGE OPEN MEDICINE, 2022, 10
  • [44] Prognosis of multi-lobar pneumonia in community-acquired pneumonia: A systematic review and meta-analysis
    Mannu, Gurdeep Singh
    Loke, Yoon Kong
    Curtain, James Peter
    Pelpola, Kelum Nadeesha
    Myint, Phyo Kyaw
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2013, 24 (08) : 857 - 863
  • [45] Global Changes in the Epidemiology of Community-Acquired Pneumonia
    Wiemken, Timothy L.
    Peyrani, Paula
    Ramirez, Julio A.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 33 (03) : 213 - 219
  • [46] Proton pump inhibitors therapy and the risk of pneumonia: a systematic review and meta-analysis of randomized controlled trials and observational studies
    Wang, Chih-Hung
    Li, Cheng-Han
    Hsieh, Ronan
    Fan, Cheng-Yi
    Hsu, Tze-Chun
    Chang, Wei-Che
    Hsu, Wan-Ting
    Lin, Yu-Ya
    Lee, Chien-Chang
    EXPERT OPINION ON DRUG SAFETY, 2019, 18 (03) : 163 - 172
  • [47] Proton pump inhibitors use and dementia risk: a meta-analysis of cohort studies
    Zhang, Yun
    Liang, Mingming
    Sun, Chenyu
    Song, Evelyn J.
    Cheng, Ce
    Shi, Tingting
    Min, Min
    Sun, Yehuan
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (02) : 139 - 147
  • [48] Risk factors for Clostridium difficile infection in hospitalized patients with community-acquired pneumonia
    Chalmers, James D.
    Akram, Ahsan R.
    Singanayagam, Aran
    Wilcox, Mark H.
    Hill, Adam T.
    JOURNAL OF INFECTION, 2016, 73 (01) : 45 - 53
  • [49] Community-acquired pneumonia
    Lorenz, Joachim
    Ewig, Santiago
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2016, 141 (07) : 486 - 489
  • [50] Common medications that increase the risk for developing community-acquired pneumonia
    Restrepo, Marcos I.
    Mortensen, Eric M.
    Anzueto, Antonio
    CURRENT OPINION IN INFECTIOUS DISEASES, 2010, 23 (02) : 145 - 151